Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors

On 18 May 2022 the FDA published the final guidance on safety considerations for labeling.

The purpose of this guidance is to help human prescription drug and biological product sponsors, application holders, and applicants minimize medication errors associated with their products. This guidance focuses on safety aspects of the application holder’s container label and carton labeling design. It provides a set of principles and recommendations for ensuring that critical elements of a product’s container label and carton labeling are designed to promote safe dispensing, administration, and use of the product.

Read more online 
Copyright Widler & Schiemann AG 2020. All Rights Reserved. /